Unveiling Keurig Dr Pepper (KDP) Q4 Outlook: Wall Street Estimates for Key Metrics
Werte in diesem Artikel
The upcoming report from Keurig Dr Pepper, Inc (KDP) is expected to reveal quarterly earnings of $0.57 per share, indicating an increase of 3.6% compared to the year-ago period. Analysts forecast revenues of $4.03 billion, representing an increase of 4.2% year over year.The consensus EPS estimate for the quarter has undergone a downward revision of 1.8% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.That said, let's delve into the average estimates of some Keurig Dr Pepper metrics that Wall Street analysts commonly model and monitor.The consensus among analysts is that 'Net Sales- U.S. Coffee' will reach $1.14 billion. The estimate indicates a change of -1.4% from the prior-year quarter.The combined assessment of analysts suggests that 'Net Sales- International' will likely reach $515.04 million. The estimate indicates a change of +4.1% from the prior-year quarter.Analysts forecast 'Net Sales- U.S. Refreshment Beverages' to reach $2.37 billion. The estimate indicates a change of +7.1% from the prior-year quarter.View all Key Company Metrics for Keurig Dr Pepper here>>>Keurig Dr Pepper shares have witnessed a change of +4.1% in the past month, in contrast to the Zacks S&P 500 composite's +2.6% move. With a Zacks Rank #3 (Hold), KDP is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Keurig Dr Pepper, Inc (KDP): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Keurig Dr Pepper und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Keurig Dr Pepper
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Keurig Dr Pepper
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Keurig Dr Pepper Inc Registered Shs
Analysen zu Keurig Dr Pepper Inc Registered Shs
Datum | Rating | Analyst | |
---|---|---|---|
17.06.2019 | Dr Pepper Snapple Group Outperform | BMO Capital Markets | |
11.07.2018 | Dr Pepper Snapple Group Hold | Stifel, Nicolaus & Co., Inc. | |
19.06.2018 | Dr Pepper Snapple Group Hold | Stifel, Nicolaus & Co., Inc. | |
19.03.2018 | Dr Pepper Snapple Group Outperform | RBC Capital Markets | |
14.03.2018 | Dr Pepper Snapple Group Buy | Stifel, Nicolaus & Co., Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
17.06.2019 | Dr Pepper Snapple Group Outperform | BMO Capital Markets | |
11.07.2018 | Dr Pepper Snapple Group Hold | Stifel, Nicolaus & Co., Inc. | |
19.06.2018 | Dr Pepper Snapple Group Hold | Stifel, Nicolaus & Co., Inc. | |
19.03.2018 | Dr Pepper Snapple Group Outperform | RBC Capital Markets | |
14.03.2018 | Dr Pepper Snapple Group Buy | Stifel, Nicolaus & Co., Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
28.07.2017 | Dr Pepper Snapple Group Neutral | UBS AG | |
09.01.2017 | Dr Pepper Snapple Group Equal Weight | Barclays Capital | |
28.10.2016 | Dr Pepper Snapple Group Neutral | UBS AG | |
28.04.2016 | Dr Pepper Snapple Group Neutral | UBS AG | |
27.10.2015 | Dr Pepper Snapple Group Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
01.12.2014 | Dr Pepper Snapple Group Underperform | RBC Capital Markets |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Keurig Dr Pepper Inc Registered Shs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen